Literature DB >> 9349463

Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo.

R M Marión1, T Zürcher, S de la Luna, J Ortín.   

Abstract

The interaction of influenza virus NS1 protein with other viral products in the infected cell was analysed by co-immunoprecipitation studies. The three subunits of the polymerase and the nucleoprotein, but not M1 protein, were co-immunoprecipitated by NS1-specific serum but not when control serum was used. Such co-immunoprecipitation was not sensitive to RNase treatment of the immunoprecipitates. Co-immunoprecipitation was also obtained when the viral transcription-replication system was reconstituted in vivo by transfection of cDNAs and model vRNA template into vaccinia virus-T7-infected cells. Analysis of the RNA pulled-down in the NS1-specific precipitates indicated the presence of both vRNA and mRNA. These results are discussed in the context of the phenotype of virus temperature-sensitive mutants affected in the NS1 gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349463     DOI: 10.1099/0022-1317-78-10-2447

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  56 in total

1.  Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response.

Authors:  Sabine Steidle; Luis Martínez-Sobrido; Markus Mordstein; Stefan Lienenklaus; Adolfo García-Sastre; Peter Stäheli; Georg Kochs
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.

Authors:  Stephan Ludwig; Xiuyan Wang; Christina Ehrhardt; Hongyong Zheng; Nicola Donelan; Oliver Planz; Stephan Pleschka; Adolfo García-Sastre; Gudrun Heins; Thorsten Wolff
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Mutations in the N-terminal region of influenza virus PB2 protein affect virus RNA replication but not transcription.

Authors:  Pablo Gastaminza; Beatriz Perales; Ana M Falcón; Juan Ortín
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response.

Authors:  Zhongfang Wang; Nicole C Robb; Eva Lenz; Thorsten Wolff; Ervin Fodor; Stephan Pleschka
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

6.  Structural and functional characterization of an influenza virus RNA polymerase-genomic RNA complex.

Authors:  Patricia Resa-Infante; María Angeles Recuero-Checa; Noelia Zamarreño; Oscar Llorca; Juan Ortín
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

7.  Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication.

Authors:  Susana de Lucas; Joan Peredo; Rosa María Marión; Carmen Sánchez; Juan Ortín
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

8.  Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification.

Authors:  J Ortega; J Martín-Benito; T Zürcher; J M Valpuesta; J L Carrascosa; J Ortín
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles.

Authors:  Urtzi Garaigorta; Ana M Falcón; Juan Ortín
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

10.  Influenza virus nucleoprotein interacts with influenza virus polymerase proteins.

Authors:  S K Biswas; P L Boutz; D P Nayak
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.